Amedisys (NASDAQ:AMED) Reaches New 1-Year Low – Should You Sell?

Amedisys, Inc. (NASDAQ:AMED)’s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as $86.31 and last traded at $87.91, with a volume of 514067 shares traded. The stock had previously closed at $91.24.

Amedisys Stock Down 1.5 %

The firm has a market capitalization of $2.78 billion, a price-to-earnings ratio of 34.23, a P/E/G ratio of 1.92 and a beta of 0.73. The stock has a 50 day moving average of $94.41 and a 200 day moving average of $95.53. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $0.98 earnings per share. As a group, analysts expect that Amedisys, Inc. will post 4.53 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Amedisys

Hedge funds have recently bought and sold shares of the company. KBC Group NV acquired a new position in Amedisys in the third quarter worth about $63,000. Innealta Capital LLC bought a new position in Amedisys in the second quarter worth about $64,000. Signaturefd LLC lifted its holdings in Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after acquiring an additional 530 shares during the last quarter. CWM LLC lifted its holdings in Amedisys by 14.5% in the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after acquiring an additional 277 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new position in Amedisys in the third quarter worth about $243,000. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.